95-10461. Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; Revision of Certain Labeling Controls; Partial Extension of Compliance Date  

  • [Federal Register Volume 60, Number 82 (Friday, April 28, 1995)]
    [Rules and Regulations]
    [Page 20897]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-10461]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Food and Drug Administration
    21 CFR Parts 210 and 211
    [Docket No. 88N-0320]
    
    Current Good Manufacturing Practice in Manufacturing, Processing, 
    Packing, or Holding of Drugs; Revision of Certain Labeling Controls; 
    Partial Extension of Compliance Date
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule; partial extension of compliance date.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing a 
    continuation of the partial extension of the compliance date for a 
    provision of the final rule, which was published in the Federal 
    Register of August 3, 1993 (58 FR 41348). The document revised the 
    current good manufacturing practice (CGMP) regulations for certain 
    labeling control provisions. In the Federal Register of August 2, 1994 
    (59 FR 39255), FDA partially extended the compliance date for a 
    provision of the regulation to August 3, 1995, and requested comments 
    on the scope of this provision. The agency is further extending the 
    compliance date to August 2, 1996. FDA is taking this action in order 
    to adequately assess comments received on the scope of a particular 
    provision of that rule.
    
    DATES: The final rule published at 58 FR 41348, August 3, 1993, is 
    effective August 3, 1994. The date for compliance with Sec. 211.122(g) 
    for items of labeling (other than immediate container labels) is 
    extended to August 2, 1996. The date of compliance for all other 
    provisions of the final rule remains August 3, 1994.
    
    FOR FURTHER INFORMATION CONTACT:
        Thomas C. Kuchenberg, Center for Drug Evaluation and Research (HFD-
    362), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 
    20855, 301-594-1046, or
        Paul J. Motise, Center for Drug Evaluation and Research (HFD-323), 
    Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 
    301-594-1089.
    
    SUPPLEMENTARY INFORMATION:
    
        In the Federal Register of August 3, 1993 (58 FR 41348), FDA 
    published a final rule that amended the CGMP regulations to require 
    that certain special control procedures be instituted if cut labeling 
    is used. One of these procedures requires the use of ``appropriate 
    electronic or electromechanical equipment to conduct a 100-percent 
    examination for correct labeling during or after completion of 
    finishing operations'' (Sec. 211.122(g)(2)).
    
        On May 4, 1994, FDA received a citizen petition from five trade 
    associations requesting that the agency take a number of actions 
    including, but not limited to, extending the August 3, 1994, effective 
    date of this rule as it applies to labeling (other than the immediate 
    container labels) as defined in section 201(m) of the Federal Food, 
    Drug, and Cosmetic Act (the act) (21 U.S.C. 321(m)). The petition 
    stated that additional time was needed because of the unavailability of 
    bar code or machine readers as well as other equipment necessary to 
    orient the labeling codes properly, and requested that FDA reopen its 
    administrative record to reassess the scope of a certain provision of 
    the regulation, as discussed below in this document.
    
         On May 6, 1994, the agency received an additional petition from a 
    trade association that requested, among other things, a 1-year stay of 
    the effective date; the petitioner stated that additional time was 
    needed to locate, install, and validate scanning equipment and other 
    necessary equipment to orient items properly for bar code scanning.
    
        Appropriate electronic or electromechanical equipment primarily 
    consists of systems that scan identity codes printed on labeling. If an 
    incorrect code is detected, the defective labeling is ejected from the 
    labeling line. FDA contacted vendors of this equipment and determined 
    that while there was not a general shortage of system hardware, there 
    was a possible shortage of contract engineering firms employed by some 
    drug manufacturers to evaluate, select, purchase, install, qualify, and 
    validate labeling verification systems.
    
        In response to this situation, FDA extended the compliance date of 
    Sec. 211.122(g) as it applied to items of labeling (other than the 
    immediate container label) to assess further the availability of 
    equipment necessary for compliance with the final rule and to evaluate 
    adequately other issues raised by petitioners.
    
        The first petition also requested that the agency reopen the 
    administrative record to receive additional comments on the application 
    of Sec. 211.122(g) to items of labeling (other than that of the 
    immediate container label) as defined in section 201(m) of the act. 
    Both citizen petitions contended that Sec. 211.122(g) expanded the 
    proposed scope of the provision from immediate container labels to all 
    drug product labeling.
        In response to the issues raised, FDA agreed to receive comments on 
    this issue and to evaluate those comments in light of the existing 
    language of Sec. 211.122(g). The comment period ended on October 4, 
    1994, and since that time FDA has had a number of meetings with 
    representatives of the labeling industry and others to determine 
    control options available through current technology and to evaluate 
    this information in light of comments received during the extended 
    comment period.
        In order to adequately assess this information, determine whether 
    any possible revision of the regulation should result, and provide 
    industry adequate time to fully comply with a final regulation, FDA is 
    extending the compliance date of Sec. 211.122(g) as its applies to 
    items of labeling other than the immediate container label to August 2, 
    1996. Should FDA determine, after completing its assessment of the 
    comments, that Sec. 211.122(g) should be retained in its current state 
    or revised, FDA will provide notice of that decision in a future issue 
    of the Federal Register. The compliance date for the remainder of 
    Sec. 211.122, including Sec. 211.122(g) as it applies to immediate 
    container labels, was August 3, 1994. The agency emphasizes, however, 
    that Sec. 211.125 makes a waiver of labeling reconciliation conditional 
    on a 100-percent examination for correct labeling performed in 
    accordance with Sec. 211.122(g)(2).
    
        Dated: April 24, 1995.
    William B. Schultz,
    Deputy Commissioner for Policy.
    [FR Doc. 95-10461 Filed 4-27-95; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Effective Date:
8/3/1994
Published:
04/28/1995
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; partial extension of compliance date.
Document Number:
95-10461
Dates:
The final rule published at 58 FR 41348, August 3, 1993, is effective August 3, 1994. The date for compliance with Sec. 211.122(g) for items of labeling (other than immediate container labels) is extended to August 2, 1996. The date of compliance for all other provisions of the final rule remains August 3, 1994.
Pages:
20897-20897 (1 pages)
Docket Numbers:
Docket No. 88N-0320
PDF File:
95-10461.pdf